These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3278439)

  • 41. Characteristics of corneal xenograft rejection in a discordant species combination.
    Ross JR; Howell DN; Sanfilippo FP
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2469-76. PubMed ID: 8325753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4+ T cells are critical for corneal, but not skin, allograft rejection.
    Haskova Z; Usiu N; Pepose JS; Ferguson TA; Stuart PM
    Transplantation; 2000 Feb; 69(4):483-7. PubMed ID: 10708099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [CTLA4-Ig prevents corneal allograft rejection in mice].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of failure rates of orthotopic corneal grafts using three different grafting procedures.
    Moticka EJ; She SC
    Curr Eye Res; 1989 Aug; 8(8):813-20. PubMed ID: 2477194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinations of serum tumor necrosis factor alpha in corneal allografts.
    Pleyer U; Milani JK; Rückert D; Rieck P; Mondino BJ
    Ocul Immunol Inflamm; 1997 Sep; 5(3):149-55. PubMed ID: 9326759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of an anti-CD4 single-chain antibody fragment from the donor cornea can prolong corneal allograft survival in inbred rats.
    Appleby SL; Jessup CF; Mortimer LA; Kirk K; Brereton HM; Coster DJ; Tan CK; Williams KA
    Br J Ophthalmol; 2013 Jan; 97(1):101-5. PubMed ID: 23172880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of class II antigen-expressing cells in corneal allograft immunity.
    Gebhardt BM
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2254-60. PubMed ID: 2242991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The extent of immunological privilege of orthotopic corneal grafts in the inbred rat.
    Katami M; Madden PW; White DJ; Watson PG; Kamada N
    Transplantation; 1989 Sep; 48(3):371-6. PubMed ID: 2675395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of indirect allorecognition in experimental late acute rejection.
    Vella JP; Vos L; Carpenter CB; Sayegh MH
    Transplantation; 1997 Dec; 64(12):1823-8. PubMed ID: 9422426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
    Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
    Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapamycin inhibits corneal allograft rejection and neovascularization.
    Olsen TW; Benegas NM; Joplin AC; Evangelista T; Mindrup EA; Holland EJ
    Arch Ophthalmol; 1994 Nov; 112(11):1471-5. PubMed ID: 7980138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of cervical and thoracic lymphadenectomy on corneal allograft rejection in inbred rats.
    Brice SL; Kirk K; Brereton HM; Coster DJ; Williams KA
    Br J Ophthalmol; 2012 Mar; 96(3):448-50. PubMed ID: 22113191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.